Assess™ is a revolutionary QSP modeling software that empowers researchers to make evidence-based decisions earlier in the drug development process enabling early feasibility assessment. Designed for non-modelers, this intuitive tool provides pre-built models across various therapeutic modalities and disease areas, enabling users to assess efficacy, safety, and therapeutic index for early stage biotherapeutics.
Assess™ QSP Software for Early Feasibility Assessment
Assess therapeutic feasibility earlier with cutting-edge modeling software designed for non-modelers.
See Assess™ QSP software in action
Pre-built pharmacology models: Quickstart your simulations with pre-configured models for biotherapeutics, gene therapy, ADCs, and more.
Interactive visualizations: Dive deep into dose-response, PK/PD plots, and feasibility criteria for enhanced understanding.
Scenario exploration: Compare multiple parameters with ease to mitigate risks and uncertainties in therapeutic development.
Why choose Assess™ for your drug development?
Assess™ simplifies complex systems pharmacology by offering a user-friendly interface combined with robust computational capabilities, especially useful in early feasibilty studies. No matter the modality of your therapy in making, whether you are exploring target selection or optimizing clinical dose requirements, this software enhances your decision-making process with actionable insights and advanced simulations.
Built-in analyses for comprehensive insights
Perform one- or two-dimensional scans with ease and visualize results through interactive plots that highlight key parameter values, including percent inhibition, activation, and target engagement.
Accelerate drug discovery with pre-configured models
Access libraries of monospecific, bispecific, and multi-compartment models tailored to various pharmacologies, from cell engagers to protein degraders.
Streamline collaboration and documentation
Save, share, and reproduce your analyses effortlessly with traceable scenario sets and automated PDF reports for your team.
Helping you answer tough questions in drug development
The power of QSP is that it can bridge the gap between biology and pharmacology to deliver a quantitative math model characterizing therapeutic pharmacology. It allows you to better understand the context of a complex biological system, disease processes, and therapeutic mechanism of action (MOA).
Improve the therapeutic effectiveness of an existing drug
Predict optimal dosing regimens and effects based on preclinical data
Predict drug effects in special populations and other indications
Gain confidence in preclinical to clinical translation of your data
Explore our Assess™ QSP model packs
Assess™ QSP software for early feasibility assessment offers several libraries of monospecific and bispecific, single compartment and multicompartment models covering common pharmacologies.
Why Certara and Assess™ QSP software
Certara’s expertise in biosimulation and strategic foresight enables us to create innovative tools like Assess™ that empower researchers to optimize therapeutic development earlier in the pipeline. By integrating advanced computational models with an intuitive interface, we provide a competitive edge to your research.
Assess™ embodies Certara’s commitment to innovation, offering robust pre-built models and interactive visualizations that address critical questions in drug discovery. With Certara, you gain not just a software solution, but a strategic partner in advancing therapeutic breakthroughs.
関連情報
全て見るSchedule a demo of Assess™
Discover how Assess™ QSP software for early feasibility studies can transform your therapeutic development process. Request a live demo or free trial today to experience this intuitive QSP modeling software firsthand. With pre-built model packs and user-friendly features, you’ll easily simulate scenarios, toggle parameters, and evaluate predictions—whether you’re a seasoned modeler or new to the field.
Gain hands-on experience with pre-built pharmacology models.
Understand how to visualize key data interactively.
Explore scenario creation for risk and uncertainty analysis.
